Skip to main content
UniHealth

Doctor search

Kailyn Lee Kim, MD

Internal Medicine · Stanford

NPI 1518595768

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • Medicare does not list them as allowed to order and refer

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kim’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A187181 · Current

Licensed to practise in California · since 2023 · expires 2027-08-31 · Sidney Kimmel Medical College at Thomas Jefferson University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Internal Medicine

Original Medicare doctor bills

$24,319

Medicare paid this office $24,319 for 156 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Initial hospital care with moderate level of medical decision making at least 75 minutes140$20,649$143
Critical care, first 30-74 minutes16$3,082$171

Who their Medicare patients are

156 Original Medicare patients in 2024. Average age 78 · Under 65 9% · 85 and older 29% · Women 47% · Also on Medicaid 42% · Health risk score 3.04. Sicker patients than 9 in 10 peers; the typical internal medicine clinician is at 1.76.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Coronary heart disease 53% · Diabetes 50% · Heart failure 45% · Atrial fibrillation 40% · Depression 35% · COPD 30% · Dementia 30% · Cancer 24% · Stroke 24%.

The office billed $146,245, Medicare allowed $32,363 and paid $24,319; for 167 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024156167783.04$146,245$24,319
2023120129772.39$104,838$19,945

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 1 service

Original Medicare services billed in 2023
Initial hospital care with moderate level of medical decision making at least 75 minutes114$18,579$154

Medicaid work

$3,731 in 2024

Medicaid paid $3,731 for 67 billed services this clinician did in 2024, up to 25 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
1ST HOSP IP/OBS HIGH 7567$3,731
Medicaid work by year
202467125$3,731
202324112$1,006
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
1ST HOSP IP/OBS HIGH 7524$1,006

Drugs they prescribed that Part D paid

$88,905

Pharmacies billed $88,905 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

40 generic and fewer than 11 brand-name prescriptions · $88,905 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Year by year

Part D prescribing by year
20244821NoneNone$88,905
2023255360% (0)None$54,785
2022363550% (0)17%$55,213
202169230% (0)None$7,721

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 5 drugs

Part D drugs prescribed in 2023
Diclofenac21$484$23
Atorvastatin19$218$11
Losartan12$163$14
Metformin13$150$12
Amlodipine Besylate11$121$11

2022: 5 drugs

Part D drugs prescribed in 2022
Diclofenac19$293$15
Atorvastatin27$256$9
Gabapentin15$230$15
Metformin21$226$11
Fluticasone Propionate16$185$12

Money from drug and device companies

$1,571 in 2025

Industry payments by year
20252752None$1,571
20241316None$440
202322None$238

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Janssen BiotechErleada$241
5 payments
  • Meals for Erleada · 2025-10-02 · $39
  • Meals for Erleada · 2025-09-02 · $32
  • Meals for Erleada · 2025-07-15 · $40
  • Meals for Erleada · 2025-05-22 · $30
  • Education for Rybrevant · 2025-05-21 · $100
E.R. Squibb & Sons L.L.C.Opdualag$154
9 payments
  • Meals for Opdivo · 2025-11-04 · $20
  • Meals for Opdivo · 2025-11-04 · $3
  • Meals for Opdualag · 2025-10-23 · $26
  • Meals · 2025-10-09 · $12
  • Meals · 2025-10-09 · $2
  • Meals · 2025-09-11 · $8
  • Meals for Opdualag · 2025-08-07 · $28
  • Meals for Opdivo · 2025-05-30 · $25
  • Meals for Opdualag · 2025-03-06 · $29
Genentech USAPolivy$113
4 payments
  • Meals for Tecentriq · 2025-12-19 · $23
  • Meals for Polivy · 2025-12-11 · $31
  • Meals for Polivy · 2025-08-15 · $32
  • Meals for Tecentriq · 2025-04-04 · $26
Servier PharmaceuticalsTibsovo$108
2 payments
  • Meals for Tibsovo · 2025-12-06 · $91
  • Meals for Tibsovo · 2025-07-09 · $18
Lilly USAVerzenio$93
2 payments
  • Education · 2025-05-14 · $61
  • Meals for Verzenio · 2025-05-02 · $32
AstraZeneca Pharmaceuticals LPLynparza$77
3 payments
  • Meals for Lynparza · 2025-11-06 · $29
  • Meals for Lynparza · 2025-05-08 · $27
  • Meals for Tagrisso · 2025-03-28 · $21
See all 52 published payments
Every published payment
Genentech USAMeals · 2025-12-19Tecentriq$23
Gilead SciencesMeals · 2025-12-18Trodelvy$31
Genentech USAMeals · 2025-12-11Polivy$31
Servier PharmaceuticalsMeals · 2025-12-06Tibsovo$91
Array BiopharmaMeals · 2025-12-04Lorbrena$28
Adc Therapeutics AmericaMeals · 2025-11-21Zynlonta$33
Agios PharmaceuticalsMeals · 2025-11-18Pyrukynd$22
AstraZeneca Pharmaceuticals LPMeals · 2025-11-06Lynparza$29
E.R. Squibb & Sons L.L.C.Meals · 2025-11-04Opdivo$20
E.R. Squibb & Sons L.L.C.Meals · 2025-11-04Opdivo$3
E.R. Squibb & Sons L.L.C.Meals · 2025-10-23Opdualag$26
E.R. Squibb & Sons L.L.C.Meals · 2025-10-09None$12
E.R. Squibb & Sons L.L.C.Meals · 2025-10-09None$2
Janssen BiotechMeals · 2025-10-02Erleada$39
Jazz PharmaceuticalsMeals · 2025-09-19Zepzelca$33
Agios PharmaceuticalsMeals · 2025-09-18Pyrukynd$23
Coherus OncologyMeals · 2025-09-16Loqtorzi$27
E.R. Squibb & Sons L.L.C.Meals · 2025-09-11None$8
AbbvieMeals · 2025-09-05Elahere$25
Alexion PharmaceuticalsMeals · 2025-09-04Ultomiris$42
Janssen BiotechMeals · 2025-09-02Erleada$32
Menarini Silicon BiosystemsMeals · 2025-08-26Cellsearch$32
Deciphera PharmaceuticalsMeals · 2025-08-19Qinlock$29
Genentech USAMeals · 2025-08-15Polivy$32
E.R. Squibb & Sons L.L.C.Meals · 2025-08-07Opdualag$28
IncyteMeals · 2025-08-05Jakafi$29
IncyteMeals · 2025-07-29Monjuvi$24
BeOne Medicines USAMeals · 2025-07-24Tevimbra$33
Menarini Silicon BiosystemsMeals · 2025-07-22Cellsearch$21
CelgeneMeals · 2025-07-18Reblozyl$18
Daiichi SankyoMeals · 2025-07-17Datroway$29
Kyowa KirinMeals · 2025-07-17Poteligeo$21
Janssen BiotechMeals · 2025-07-15Erleada$40
Servier PharmaceuticalsMeals · 2025-07-09Tibsovo$18
E.R. Squibb & Sons L.L.C.Meals · 2025-05-30Opdivo$25
Karyopharm TherapeuticsMeals · 2025-05-29Xpovio$29
Janssen BiotechMeals · 2025-05-22Erleada$30
Janssen BiotechEducation · 2025-05-21Rybrevant$100
Lilly USAEducation · 2025-05-14None$61
AstraZeneca Pharmaceuticals LPMeals · 2025-05-08Lynparza$27
Lilly USAMeals · 2025-05-02Verzenio$32
SeagenEducation · 2025-04-24None$75
PfizerMeals · 2025-04-24Ibrance$32
ExelixisMeals · 2025-04-10Cabometyx$41
Genentech USAMeals · 2025-04-04Tecentriq$26
Blueprint MedicinesMeals · 2025-04-03Ayvakit$36
CelgeneMeals · 2025-04-02Reblozyl$16
AstraZeneca Pharmaceuticals LPMeals · 2025-03-28Tagrisso$21
CelgeneMeals · 2025-03-07Reblozyl$16
E.R. Squibb & Sons L.L.C.Meals · 2025-03-06Opdualag$29
CelgeneMeals · 2025-01-17Reblozyl$18
GeronMeals · 2025-01-16Rytelo$24
See earlier years (2024, 2023)

2024: $440

Payments by company in 2024
CelgeneReblozyl$89
3 payments
  • Meals for Reblozyl · 2024-09-27 · $30
  • Meals for Reblozyl · 2024-09-19 · $31
  • Meals for Reblozyl · 2024-08-30 · $28
AstraZeneca Pharmaceuticals LPTagrisso$51
2 payments
  • Meals for Lynparza · 2024-08-15 · $21
  • Meals for Tagrisso · 2024-07-10 · $30
Agios PharmaceuticalsNone$39
1 payment
  • Meals · 2024-10-24 · $39
Janssen BiotechDarzalex$32
1 payment
  • Meals for Darzalex · 2024-10-18 · $32
Ipsen BiopharmaceuticalsOnivyde$32
1 payment
  • Meals for Onivyde · 2024-11-21 · $32
Karyopharm TherapeuticsXpovio$30
1 payment
  • Meals for Xpovio · 2024-09-05 · $30
BeiGene USABrukinsa$29
1 payment
  • Meals for Brukinsa · 2024-10-31 · $29
ExelixisCabometyx$28
1 payment
  • Meals for Cabometyx · 2024-11-22 · $28
X4 PharmaceuticalsXolremdi$28
1 payment
  • Meals for Xolremdi · 2024-12-05 · $28
E.R. Squibb & Sons L.L.C.Opdivo$23
1 payment
  • Meals for Opdivo · 2024-07-18 · $23
Genentech USATecentriq$21
1 payment
  • Meals for Tecentriq · 2024-08-22 · $21
Aveo PharmaceuticalsFotivda$20
1 payment
  • Meals for Fotivda · 2024-12-13 · $20
AbbvieElahere$18
1 payment
  • Meals for Elahere · 2024-08-08 · $18

2023: $238

Payments by company in 2023
Melinta TherapeuticsVabomere$130
1 payment
  • Meals for Vabomere · 2023-04-19 · $130
Astellas Pharma USCresemba$108
1 payment
  • Meals for Cresemba · 2023-10-03 · $108

Professional record

NPI
1518595768
Licence
CA A187181California A187181: Current · expires 2027-08-31
More record details
Sole proprietor
No
Taxonomy
Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2020-03-31
NPI last updated
2024-04-19
NPI record certified
2024-04-19

This is when the NPI record was last certified, not a medical board exam.